- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Amarantus Bioscience Holdings Inc+ Add to Watchlist
AMBS:US0.0595 USD 0.0085 16.67%
As of 20:10:04 ET on 03/26/2015.
Company Profile for Amarantus Bioscience Holdings Inc (AMBS)
Amarantus Bioscience Holdings, Inc. is a biotechnology holding company. The Company, through its subsidiaries, certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, traumatic brain Injury, Ischemic heart disease and other human diseases.
Amarantus Bioscience Holdings Inc
Key Executives for Amarantus Bioscience Holdings Inc (AMBS)
|Gerald E CommissiongPresident/CEO/COO||Robert FarrellChief Financial Officer|
|John W CommissiongChief Scientific Ofcr/Co-Founder||Elise BrownellSenior VP:Ops & Project Mgmt|
|Marc E FaerberVP:Financial Ops/Treasurer||Aimee BoutcherInvestor Relations|